Idecabtagene vicleucel

idecabtagene vicleucel · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Idecabtagene vicleucel, covering 2025-12-12 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel [Phase 2]